Raphaël Leblanc
Impact in
-
- MicroRNA in disease regulation
- Oncology top 10%
- Inflammatory Biomarkers in Disease Prognosis
- Cancer Cells and Metastasis
Papers in
-
- Hippo pathway signaling and YAP/TAZ 5
-
- Sphingolipid Metabolism and Signaling 9
- Ubiquitin and proteasome pathways 5
- Extracellular vesicles in disease 4
- Protein Degradation and Inhibitors 2
- Protein Kinase Regulation and GTPase Signaling 2
- Co-authors
- Olivier Peyruchaud (11 shared papers)Debashish Sahay (4 shared papers)Marion David (4 shared papers)Johnny Ribeiro (4 shared papers)Philippe Clézardin (4 shared papers)Pascale Zimmermann (8 shared papers)Jean‐Claude Bordet (1 shared paper)Sue Çhin Lee (1 shared paper)
- Journals
- Proceedings of the National Academy of Sciences (2 papers)Blood (2 papers)Oncotarget (2 papers)Journal of Medicinal Chemistry (2 papers)Microscopy and Microanalysis (1 paper)
- Partner nations
- FranceBelgiumUnited States
In The Last Decade
Raphaël Leblanc
22 papers receiving 887 citations
Peers
Comparison fields: 5 of 70
- Cancer Research 162
- Oncology 284
- Cell Biology 182
- Internal Medicine 29
- Molecular Biology 568
Countries citing papers authored by Raphaël Leblanc
This map shows the geographic impact of Raphaël Leblanc's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raphaël Leblanc with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raphaël Leblanc more than expected).
Fields of papers citing papers by Raphaël Leblanc
This network shows the impact of papers produced by Raphaël Leblanc. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raphaël Leblanc. The network helps show where Raphaël Leblanc may publish in the future.
Co-authors
The 25 scholars most cited alongside Raphaël Leblanc, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 187 | |
| 2 | 2014 | 145 | |
| 3 | 2014 | 90 | |
| 4 | 2020 | 87 | |
| 5 | 2015 | 59 | |
| 6 | 2018 | 47 | |
| 7 | 2014 | 43 | |
| 8 | 2020 | 41 | |
| 9 | 2018 | 32 | |
| 10 | 2012 | 31 | |
| 11 | 2019 | 25 | |
| 12 | 2014 | 25 | |
| 13 | 2016 | 16 | |
| 14 | 2021 | 15 | |
| 15 | 2021 | 15 | |
| 16 | 2023 | 13 | |
| 17 | 2021 | 11 | |
| 18 | 2023 | 6 | |
| 19 | 2023 | 5 | |
| 20 | 2021 | 2 |
About Raphaël Leblanc
Raphaël Leblanc is a scholar working on Cell Biology, Molecular Biology, Immunology and Allergy, Cancer Research and Pulmonary and Respiratory Medicine, having authored 22 papers that have together received 897 indexed citations. Recurring topics across this work include Sphingolipid Metabolism and Signaling (9 papers), Hippo pathway signaling and YAP/TAZ (5 papers), Ubiquitin and proteasome pathways (5 papers), Extracellular vesicles in disease (4 papers), Cell Adhesion Molecules Research (3 papers), Prostate Cancer Treatment and Research (2 papers), Protein Degradation and Inhibitors (2 papers) and Protein Kinase Regulation and GTPase Signaling (2 papers). The work is most often cited by research in Cancer Research (162 citations), Oncology (284 citations), Cell Biology (182 citations), Internal Medicine (29 citations) and Molecular Biology (568 citations). Raphaël Leblanc has collaborated with scholars based in France, Belgium and United States. Frequent co-authors include Olivier Peyruchaud, Debashish Sahay, Marion David, Johnny Ribeiro, Philippe Clézardin, Pascale Zimmermann, Jean‐Claude Bordet, Sue Çhin Lee, Duane D. Miller and Derek D. Norman. Their work appears in journals such as Proceedings of the National Academy of Sciences, Blood, Oncotarget, Journal of Medicinal Chemistry and Microscopy and Microanalysis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.